LEO Pharma

Psoriasis does not only affect those living with it, but also their family members. This World Psoriasis Day, LEO Pharma supports IFPA in promoting understanding and helping fight misinformation about the condition that affects at least 100 million people globally – and their family members. A general lack of awareness of psoriasis leads to misconceptions about the disease, resulting in stigmatization and discrimination. This can negatively impact the psychological health of psoriasis patients and their families – who experience similar levels of anxiety and depression. Creating awareness is a crucial step towards increasing acceptance and fighting stigma and ignorance that negatively affect the quality of life of the psoriatic family. Let’s support those living with psoriasis – and those around them. #LEOPharma #DermatologyBeyondTheSkin #WorldPsoriasisDay2024 #WPD2024 #PsoriaticFamily

October 13 is observed as World Thrombosis Day 🩸 Thrombosis, caused by blood clots forming in blood vessels, is an urgent and growing health problem. Thrombosis-related conditions, such as heart attacks and strokes, account for 1 in 4 deaths worldwide. Today, LEO Pharma joins the global efforts of the World Thrombosis Day organization in their mission to spread awareness about this often-silent threat and its prevention. Together, let's make a difference in saving lives. Remember, awareness leads to action, and action saves lives. Today, take that first step (and more) towards preventing Thrombosis by staying active! 🏃️ For more life-saving knowledge on Thrombosis, please visit https://lnkd.in/eqSKqPf #LEOPharma #MoveAgainstThrombosis #WorldThrombosisDay

As a purpose-driven company, we recognize our responsibility to minimize negative environmental impacts and contribute to a more sustainable future. LEO Pharma is announcing its commitment to long-term company-wide emission reductions in line with science-based net-zero with the Science-Based Target initiative (SBTi) by 2050. This commitment will involve an extensive decarbonization plan across the company’s operations, aligning with the Paris Agreement. This will be subject to validation from the SBTi which will be made within 24 months of this commitment. #DermatologyBeyondTheSkin #NetZero #LEOPharma

The impact of skin conditions goes beyond the skin. This World Mental Health Day, LEO Pharma aims to shed light on the psychological burden that skin diseases have on people’s lives. Skin diseases are the fourth most common of all human diseases, affecting almost one-third of the world’s population, yet their burden is often underestimated. Besides physical impact, skin diseases can affect psychological well-being in many ways, including feelings of embarrassment, stigmatization, sleeping difficulty, anxiety, depression and an impaired quality of life. In fact, people living with skin diseases consistently report that the psychological aspects are a major component of their disease — more than the physical symptoms for many. LEO Pharma is committed to raising awareness about the burden of skin conditions and to advancing the standard of care for those who need us most in medical dermatology. #LEOPharma #DermatologyBeyondTheSkin #WorldMentalHealthDay

We were thrilled to attend the #EADVCongress and showcase our extensive data and expertise across several skin conditions. Our onsite team acquired valuable insights that will help further our mission of advancing the standard of care in medical dermatology. Thank you to all those who stopped by our booth - it was a pleasure meeting each and every one of you. #DermatologyBeyondTheSkin #LEOPharma

Our late-breaker presentation to support those living with #AtopicDermatitis has just come to an end at the European Academy of Dermatology and Venereology Congress. That makes 5 late-breaker presentations LEO Pharma has presented this week! In addition, 23 other scientific posters were presented for a range of skin conditions, truly reinforcing our dedication to addressing the needs of those living with skin conditions. #DermatologyBeyondTheSkin #LEOPharma

🎤Reporting live from the #EADVCongress Our late-breaker presentation to support those living with #AtopicDermatitis has just finished at the European Academy of Dermatology and Venereology Congress. Keep an eye out for more such exciting updates in the coming days… #DermatologyBeyondTheSkin

🎤Reporting live from the #EADVCongress One of our late-breaker presentations for #ChronicHandEczema has just concluded at this year’s European Academy of Dermatology and Venereology. We look forward to showcasing the rest of our scientific programme in the coming days. #DermatologyBeyondTheSkin

We are excited to be onsite at the #EADVCongress in Amsterdam and look forward to unveiling our most extensive scientific programme to date, including 5 late-breakers and 23 scientific posters to support those living with a range of #SkinConditions. Visit our booth at #B28 and meet our team on the ground. #DermatologyBeyondTheSkin #LEOPharma

We are EADV ready! This week, LEO Pharma is in Amsterdam for #EADVCongress 2024, where we will showcase a variety of new clinical and real-world data for a range of skin conditions. We are looking forward to collaborating on the latest advances in medical dermatology We will be at booth B28 – see you all soon! #DermatologyBeyondTheSkin #LEOPharma